Lupin is currently trading at Rs. 1595.15, up by 14.60 points or 0.92% from its previous closing of Rs. 1580.55 on the BSE. 

The scrip opened at Rs. 1595.00 and has touched a high and low of Rs. 1602.50 and Rs. 1588.15 respectively. So far 7418 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1703.80 on 11-Mar-2024 and a 52 week low of Rs. 680.35 on 27-Apr-2023.

Last one week high and low of the scrip stood at Rs. 1634.00 and Rs. 1541.05 respectively. The current market cap of the company is Rs. 72646.57 crore.

The promoters holding in the company stood at 47.01%, while Institutions and Non-Institutions held 46.05% and 6.93% respectively.

Lupin has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Aurangabad manufacturing facility. The inspection was conducted from March 6 to March 15, 2024. The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI). 

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

1663.00 15.25 (0.93%)
03-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.